Visiongain¡¦s 3rd annual Pain Management conference will focus on the pharmacological approach to relieving pain, with a look at cannabis based medicines, imaging pain and therapies to treat neuropathic pain. During the two days, a wide range of case studies on novel drugs will be examined, as well as an insight into targeting pain relief in women. This 3-day event is the ideal platform for those interested in building new alliances, making investments and developing partnerships.

Attend this event to:
„h Learn about future analgesics
„h Discover the role of sensory neurone specific receptors in pain
„h Explore the benefits of cannabis-based medicines
„h Understand the new preclinical requirements for clinical trials
„h Identify different pain models and targets
„h Examine how the mechanism of pain can be understood by functional brain imaging

Key Speakers: „h Pfizer „h GlaxoSmithKline „h GSK Consumer Healthcare „h Novartis „h Merck „h Astra Zeneca „h Dov Pharmaceuticals „h MEDA Pharma „h GW Pharmaceutical „h Imperial College London „h Manchester University/Hope Hospital „h Neurotargets „h AlcaSynn „h Cognitive Drug Research